RTW INVESTMENTS, LP - 31 Dec 2024 SCHEDULE 13G/A Report for SAB Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (SABS)

Filing Manager: RTW INVESTMENTS, LP
Reporting Manager: RTW Investments, LP
Security: SAB Biotherapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: SABS
Shares outstanding: 10,253,604 shares
Disclosed Ownership: 1,024,335 shares
Ownership: 10%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 09:00:04 UTC
Date of event: 31 Dec 2024
Next filing: 17 Feb 2026
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
RTW Investments, LP	10%	1,024,335	0	1,024,335	/s/ Roderick Wong, M.D.	Roderick Wong, M.D., Managing Partner
Roderick Wong, M.D.	10%	1,024,335	0	1,024,335	/s/ Roderick Wong, M.D.	Roderick Wong, M.D.